Introducing newnormal.health – a message from Roberto Ascione, CEO Healthware Group
Dear Friends and Partners,
The unique conditions that the pandemic and associated lockdowns generated have acted as a catalyst, accelerating digital transformation across all companies.
Thanks to our long-lasting commitment to digital health, we were pleased to find ourselves ready to support our partners with innovative ideas and technological solutions since almost the very beginning of this global challenge.
Back in February, demonstrating our commitment to helping, we created a Strategic Response Framework for our clients and partners. This first provided support with remote and business continuity strategies to safeguard already planned initiatives in the short term, followed by more medium term solutions to replace medical conferences and support field teams trying to keep in touch with physicians.
newnormal.health is a new online resource that aggregates information and analysis on how to respond to the huge changes COVID-19 has wrought across life sciences and healthcare.
Launched by Healthware Group, it aims to help guide executives from pharma, biotech and medical device companies in their response to the pandemic and its aftermath.
The open access newnormal.health contains content from Healthware and its partners, and covers customer engagement, digital health, digital transformation, and trends and perspectives on future scenarios for the industry.
These include looking at how AI can help fight COVID-19, the ascent of telemedicine, drivers of change within pharmaceutical marketing and future roles for digital therapeutics.